Four-domain voltage-gated Ca 2+ and Na + channels (Ca V , Na V ) underpin nervous system function and likely emerged upon intragenic duplication of a primordial two-domain precursor. To investigate if two-pore channels (TPCs) may represent an intermediate in this evolutionary transition, we performed molecular docking simulations with a homology model of TPC1, which suggested that the pore region could bind antagonists of Ca V or Na V . Ca V or Na V antagonists blocked NAADP (nicotinic acid adenine dinucleotide phosphate)-evoked Ca 2+ signals in sea urchin egg preparations and in intact cells that overexpressed TPC1. By sequence analysis and inspection of the model, we predicted a noncanonical selectivity filter in animal TPCs in which the carbonyl groups of conserved asparagine residues are positioned to coordinate cations. In contrast, a distinct clade of TPCs [TPCR (for TPC-related)] in several unicellular species had ion selectivity filters with acidic residues more akin to Ca V . TPCRs were predicted to interact strongly with Ca V antagonists. Our data suggest that acquisition of a "blueprint" pharmacological profile and changes in ion selectivity within four-domain voltage-gated ion channels may have predated intragenic duplication of an ancient two-domain ancestor.
INTRODUCTION
The voltage-gated ion channel superfamily is critical for a plethora of cellular processes in both excitable and nonexcitable cells (1) . Voltage-gated Ca 2+ channels (Ca V s) drive neurotransmitter release at nerve terminals, thereby sustaining action potentials propagated by voltage-gated Na + channels (Na V s) (2) . Mutations in the genes encoding these proteins underlie many diseases ("channelopathies"), including migraine, arrhythmias, and epilepsy (3) . Both Ca V and Na V are composed of four homologous domains (DI to DIV) that assemble in a pseudotetrameric arrangement (Fig. 1A) . Each domain comprises six membrane-spanning regions (S1 to S6), which form the voltage sensor (S1 to S4) and pore (S5 and S6) (1) . Ca V and Na V are targeted clinically by various drugs-including antihypertensives, antiarrhythmics, anticonvulsants, and local anesthetics-primarily through interactions with S6 (4, 5) . The reentrant pore loops (p-loops) located between S5 and S6 control ion selectivity. Much is known about the structure-function relationships for these proteins, including atomic insight into prokaryotic Na V homologs (6) (7) (8) (9) . Two-pore channels (TPCs) are less well-characterized voltage-gated ion channels (10) . Similar to Ca V and Na V , TPCs are modular proteins that are also likely to be pseudotetrameric (11) (12) (13) , but they have a distinctive structure comprising only two homologous channel domains (Fig. 1A) . Additionally, they are not present on the plasma membrane but rather on acidic intracellular organelles that function as Ca 2+ stores (14) . In plants, they localize to the vacuole and correspond to slow vacuolar channels that underlie the slow vacuolar current in response to Ca 2+ and voltage (15) . In animals, TPCs localize to the analogous vesicles within the endosomal and lysosomal system, but their function is not entirely clear. Multiple studies suggest that TPCs are the target for the Ca 2+ -mobilizing messenger nicotinic acid adenine dinucleotide phosphate (NAADP) (16) (17) (18) . NAADP mobilizes Ca 2+ from acidic organelles to regulate a multitude of events in various cells, including sea urchin eggs where its Ca 2+ -mobilizing activity was first described (19, 20) . Gating of TPCs by NAADP, however, is complex and likely involves accessory proteins and coactivation by the phosphoinositide phosphatidylinositol 3,5-bisphosphate [PI(3,5)P 2 ] (21-23). The pharmacology of TPCs is ill-defined, and the permeability properties of TPCs vary substantially between studies with reports concluding that TPCs are nonselective (24, 25) or selective for Ca 2+ (26) , Na + (22) , or H + (27) . Na V s are thought to have evolved from Ca V s (2) , and their emergence can be traced to unicellular organisms that were the ancestors of fungi and animals (28, 29) . Ca V -like selectivity filters in Na V s from basal lineages support the Ca Vto-Na V transition (28) , as do functional analyses demonstrating Ca 2+ permeability of select Na V homologs from Nematostella vectensis, a simple eumetazoan (30) . Na V s are also present in bacteria (31) , but bacterial Na V s are singledomain proteins that likely acquired Na + selectivity independently of animal Na V s (32) . The topological similarities between the four domains of animal Ca V and Na V with the single domain of voltage-gated K + channels, which assemble as tetramers, have led to the proposal that four-domain channels evolved after two rounds of intragenic duplication of a primordial, singledomain precursor (2) . The duplicated domain organization of TPCs makes them possible descendants of the putative evolutionary two-domain intermediate (33) . TPCs may therefore hold a key position in the evolution of the voltage-gated ion channel superfamily. Definition of their properties is thus important for reconstructing ancestry of ion channel attributes. Here, we provide evidence that the structural determinants underlying channel blockade by pharmacological antagonists and ion selectivity may have been acquired before intragenic duplication of primeval two-domain channels. Key features of extant voltage-gated ion channels thus emerged early in their evolution. intragenic duplication to give rise to fourdomain channels (2) . The phylogeny of extant two-and four-domain channels, however, is ill-defined and difficult to establish, given sequence divergence. We divided TPCs, Ca V , and Na V members of the voltage-gated ion channel superfamily (table S1) into their individual channel domains (S1 to S6). Ancestry was then probed through an "alldomain" phylogenetic analysis using the DI to DIV segments of Na V and Ca V and the DI and DII segments of TPCs (Fig. 1B) . For Ca V and Na V , DI grouped with DIII, whereas DII grouped with DIV, consistent with an ancestral duplication event (34) . TPC domains appear phylogenetically closer to individual domains of Ca V and Na V than to each other (Fig. 1B) . DI of TPCs grouped with DI and DIII of Ca V s and Na V s (green), whereas DII of TPC grouped with DII and DIV of Ca V s and Na V s (purple). Each domain of TPCs may therefore be related to counterparts in Ca V and Na V , supporting a common ancestry.
Ca V antagonists target the pore region of TPCs

Ca
2+ and Na + channel antagonists are thought to bind to similar regions within the pore of their respective four-domain channels. Overlap in the molecular determinants underlying drug binding and channel regulation suggests a similar structural motif for pharmacological block (35) . Because TPCs, Ca V s, and Na V s are likely descended from a common ancestor, all of these voltagegated ion channels may contain a similar structural motif within their pore regions. To test this, we generated homology models for the pore regions (S5 and S6) of TPC, Ca V , and Na V for molecular docking analyses. The pore regions of TPCs and the single-domain prokaryotic Na + channels exhibit high sequence similarity ( Fig. 2A) , especially within S5, S6, and the first pore helix [pore helix 1 (PH1)]. Therefore, we used the crystal structure of Na V from Arcobacter butzleri [Protein Data Bank (PDB) ID: 3RVY] (6) as a template for homology modeling. In the structural model, TPC adopted the characteristic pyramidal structure in which four inner helices (S6) cross to form a closed bundle near the cytosolic entrance (Fig. 2B) .
To test whether TPCs could bind Ca V blockers, we performed molecular docking studies with dihydropyridines, antagonists of L-type Ca V (Fig. 3A and Table 1 ). We successfully docked a series of dihydropyridines to the pore region of TPC (Fig. 3A) . Analogs were tightly clustered and centrally placed in the inner cavity. The predicted free energy . Each domain (DI to DIV) comprises six transmembrane regions (S1 to S6, numbered). S1 to S4 form the voltage-sensing domain (VSD) and S5 and S6 form the pore (P). Arrows depict the direction of ion flow into the cytosol from either the extracellular space (Ca V and Na V ) or the lumen of acidic organelles (TPC). (B) Unrooted maximum likelihood tree constructed using sequences of individual domains of TPCs, Ca V s, and Na V s from representative members of the chordate, cephalachordate, echinoderm, and cnidarian phyla. Species used were Homo sapiens (Hsa), the sea squirt Ciona intestinalis (Cin), the sea urchin S. purpuratus (Spu), and the starlet sea anemone N. vectensis (Nve). Accession numbers are listed in table S1. Bootstrap values at the basal branches are shown. All other values were 40 to 100. Similar domains inferred from the phylogenetic relationships are shaded green (I and III) and pink (II and IV) in (B) and connected by the colored lines in (A).
(DG) values were −4.7 to −6.5 kcal/mol (Table 1) . We also docked the dihydropyridines onto models of Ca V and Na V and calculated DG values for each antagonist ( Table 1) . As expected, dihydropyridines docked to Ca V within a tight cluster biased toward the DIII-DIV interface (Fig. 3B) . Although dihydropyridines docked to Na V , the poses were less clustered than for TPC or Ca V , segregating into either the inner cavity or the DII-DIII interface of Na V (Fig. 3C ). This lack of consensus was most apparent from an overlay of the volume occupied by the analogs in the three channel types (Fig. 3D) . The DG values were generally higher (less negative) for Na V (−3.1 to −6 kcal/mol) than for TPC and Ca V (Fig. 3D and Table  1 ), predicting a rank order of potency for dihydropyridines of Ca V > TPC > Na V (Fig. 3D) . Additionally, verapamil (a phenylalkamine class of L-type Ca V antagonists) and diltiazem (a benzothiazepine class of Ca V antagonists) also docked to TPC ( Fig. 3E and Table 1 ). Thus, the molecular docking simulations suggested that TPCs can bind Ca V antagonists.
Multiple studies, although not all, indicate that TPCs are activated by NAADP (16, 17, 22, 23) . Several Ca V antagonists block NAADP-evoked Ca 2+ signals in sea urchin egg homogenates (36) and TPC-dependent Na + currents in cells overexpressing TPC (22, 37) . Using the sea urchin egg homogenate preparation, we showed that nifedipine, isradipine, verapamil, and diltiazem all inhibited NAADP-induced Ca 2+ release (Fig. 3F) . Thus, the molecular docking simulations and the NAADP-stimulated, Ca 2+ release assay suggest that Ca V antagonists target and block the TPC pore.
Na V antagonists target the pore region of TPCs
To test whether TPCs are targeted by Na V antagonists, we performed a similar analysis using a series of 10 drugs, typified by the local anesthetic lidocaine. As with the Ca V antagonists, the Na V antagonists docked in a tight cluster within the TPC pore ( Fig. 4A ) and bound with DG values that were similar to those calculated for these antagonists with the Na V model (Table 2 and fig. S1 ). Lidocaine blocked NAADP-evoked Ca 2+ signals in the sea urchin egg homogenate preparation but had little effect on Ca 2+ released in response to cyclic adenosine 5′-diphosphate ribose (cADPR) (Fig. 4B ), which is mediated by ryanodine receptors (38) . This was expected because, although ryanodine receptors are also intracellular channels that are permeable to Ca 2+ , they are structurally distinct from TPCs (38) . Indeed, molecular docking indicated that ryanodine interacted weakly with the TPC pore (DG = −3.03 kcal/mol). Bupivacaine, a local anesthetic and antiarrhythmic agent, also selectively inhibited NAADP responses (Fig. 4 , B and C). The effects of lidocaine and bupivacaine on NAADP responses were concentrationdependent with half-maximal inhibitory concentrations (IC 50 ) of 1.1 ± 0.2 and 0.1 ± 0.02 mM (n = 3), respectively ( and sea urchin (Spu) TPCs (outlined with dashes in schematic) with prokaryotic Na V s from A. butzleri (Abu) and Rickettsiales sp. HIMB114 (Rhi). Positions of S5 and S6 in Na V s are indicated with the purple bars, the intervening turret region with a gray bar, the first (PH1) and second (PH2) pore helices with green bars, and the selectivity filter (SF) with a yellow bar. Large insertions within the corresponding turret regions of TPCs (^) were omitted from the alignment for clarity. Residues that coordinate cations in Na V are shaded cyan. Conserved asparagine residues in TPCs within the selectivity filter are yellow. Black shading indicates sequence identity, and gray indicates conserved substitution. (B) Homology model of the pore of sea urchin TPC1 in side (left), cytosolic (middle), and luminal (right) orientations. Side views are depicted in an upright (as opposed to inverted) "tepee" fashion to reflect their organellar (as opposed to plasma membrane) subcellular localization.
to ion conduction in Ca V (Fig. 5A) . The projection of nicardipine into the DIII-DIV interface of Ca V is similar to previously reported docking models for dihydropyridines (39) .
We observed similar disparities upon close inspection of the poses for local anesthetics docked in TPC or in Na V . The poses for several drugs were perpendicular in TPC compared with their poses in Na V (Fig. 5B) . The poses in Na V , exemplified by mepivacaine, are consistent with the pose reported for etidocaine docked in Na V (40) . Intriguingly, we noted congruence in poses for a range of Ca V (nicardapine, verapamil, and diltiazem) and Na V (mepivacaine) antagonists with regard to their docked positions at the cytosolic end of the TPC pore (Fig. 5C) . The identified interacting residues in TPC for these antagonists mapped to S6 in each of the domains (Fig. 5D) Fig. 5D, bold residues) . These residues are among those identified by site-directed mutagenesis in mediating the effects of phenylalkamines in Ca V (41) and local anesthetics and anticonvulsants in Na V (42) (Fig. 5B, underlined residues) . These data indicated that Ca V and Na V antagonists likely interact at a common site in TPCs.
To test if the modeled docking data correlated with the inhibitory effects of these Ca V and Na V antagonists on NAADPstimulated Ca 2+ release, we compared predicted DG from the docking analyses to IC 50 from the sea urchin egg Ca 2+ release assays (Fig. 5E ). The in silico experiments and the functional assays were positively correlated (Fig. 5E ). These data support the hypothesis that TPCs are targets for both Ca V and Na V antagonists.
Despite the correlation between "dry" and "wet" pharmacology, some of the antagonists of Ca V s or Na V s are not entirely selective for their target four-domain channels, leaving open the possibility that our docking and functional analyses are unrelated. To bolster our hypothesis, we analyzed veratridine, which is considered a selective Na V agonist (43) . Similar to the Na V antagonists, veratridine inhibited NAADP-induced, but not cADPRinduced, Ca 2+ release in a concentrationdependent manner (Fig. 5, F and G) . This inhibition is similar to the reported inhibitory effects of the Ca V agonist BayK 8644 on NAADP-stimulated Ca 2+ responses (36) . TPCs thus appear to have a pharmacological site that is related to, but clearly distinct from, both Ca V and Na V .
Ca V and Na V modifiers inhibit recombinant TPC1
To further investigate the functional effects of Ca V and Na V antagonists on TPC activity, we characterized NAADP-evoked Ca 2+ signals in intact SKBR3 cells expressing TPC1 (Fig. 6) . Consistent with our previous analysis (44) , microinjection of NAADP evoked robust Ca 2+ signals in TPC1-expressing cells compared to mock-transfected cells (Fig. 6A) . Bath exposure to nifedipine inhibited NAADP-evoked response in a concentration-dependent manner (Fig. 6 , B and C) with an IC 50 (4 mM) similar to that observed for blockade of endogenous NAADP responses in sea urchin egg homogenates (27 mM, Fig. 5E ). Both lidocaine and veratridine also blocked Ca 2+ signals stimulated by NAADP in TPC1-expressing cells (Fig. 6D) .
TPCs have noncanonical selectivity filters
Ca V s and Na V s are highly selective for their respective ions, with well-defined selectivity filters comprising conserved residues in each of the four domains (typically "EEEE" in Ca V s and "DEKA" in Na V s) (1). The ion selectivity of TPCs is not clear, and no structural information is available. Inspection of the model indicated that the central cavity of TPC is constricted at the luminal end by short helices in DI (residues 278 to 282) and DII (residues 637 to 640) corresponding to the selectivity filter of AbuNa V (Fig. 2A, yellow region) . There was a notable absence of conserved charged residues in this region, consistent with studies demonstrating poor ion selectivity of TPC2 (24, 25) . The alanine residue in DIV of selectivity filters in Na V , however, was present in the TPC model, although the lysine of DIII, thought to be critical for Na + selectivity through electrostatic repulsion of Ca 2+ (45), was not. We identified asparagine residues that were highly conserved in animal TPCs (Fig. 2A , residues highlighted in yellow), and the carbonyl groups of the side chains projected into the pore and therefore could be appropriately positioned to coordinate cations (Fig. 7A) . This arrangement is similar to (46) but differs from the selectivity filters of Ca V and Na V . Indeed, the position of these putative coordinating residues is not obvious from linear sequence alignment with Ca V and Na V ( Fig. 2A) (33) . Thus, the modeling data suggest that TPCs have noncanonical selectivity filters compared with the four-domain voltage-gated ion channels.
Unicellular organisms have a distinct clade of TPCs
The modeling data indicated that selectivity filters of TPCs are divergent from Ca V and Na V . When did these structural changes occur? To gain insight into the evolution of ion selectivity, we inspected the genomes of unicellular organisms that hold key positions in animal evolution for TPC homologs ( Fig. 7B and table S2 ). TPCs are present in the choanoflagellates Monosiga brevicollis and Salpingoeca rosetta, which represent close unicellular relatives of animals (47) . TPCs are also present in Capsaspora owczarzaki, a holozoan, and Thecamonas trahens, an apusozoan protist, both of which are more distantly related to animals. T. trahens belongs to the putative unicellular sister group to Opisthokonta (animals, fungi, and related protists) (48) . Three of these unicellular species have multiple genes encoding TPCs (Fig. 7B) . We used TPC sequences from these species together with those from human and sea urchin to perform a phylogenetic classification (Fig. 7C) . We identified homologs of the three-member TPC family characteristic of deuterostome animals (44) . However, the remaining isoforms grouped as a previously unreported clade, which we term TPCR (for TPC-related; Fig. 7C ).
The selectivity filters of TPCRs are distinct Unicellular TPC1 to TPC3 homologs had putative selectivity filters similar to the asparagine-lined filters predicted for animal TPCs (Fig. 7C) . The residues that were predicted to function as the selectivity filters of TPCR were divergent. For example, in DI, the putative coordinating asparagine residue was conserved, but the preceding residue was acidic and aligned with the coordinating acidic residues in Ca V (Fig. 7C) . The presence of acidic or polar serine residues was also noted in DII (Fig. 7C) . The identification of such residues in the putative selectivity filter of TPCRs suggested similarities with Ca V s. Together, these analyses indicate that multiplication of the TPC gene may have occurred before the animal-fungal split and was followed by changes in ion selectivity within a select TPC cohort corresponding to the ancestors of Ca V and Na V . Acquisition of ion selection thus may have occurred before the intragenic duplication event that gave rise to four-domain channels.
TPCRs interact strongly with Ca V antagonists
Because the putative selectivity filter of the TPCR family appeared more similar to the Ca V s, we generated homology models for select members of TPCR and TPC from S. rosetta (for which sequences of the pore appear complete) and compared docking of dihydropyridines. The molecular docking simulations showed that all but one of the dihydropyridines docked in a tight cluster at a domain interface in TPCR (Fig. 7D) , which is similar to the interaction of dihydropyridines with the DIII-DIV interface in animal Ca V (Fig. 3B) . In contrast, dihydropyridine poses in the unicellular TPC models were less clustered and more central (Fig. 7D) , thus resembling data from animal TPC (Fig. 3A) . The predicted DG values indicated that the interaction of dihydropyridines was stronger for TPCR than for TPC (Table 3) . These data provide further support that TPCRs are similar to Ca V s.
DISCUSSION
Here, we identified a putative common binding site within TPCs for Ca V and Na V antagonists together with a relatively "loose" pharmacological profile. These data suggested that this motif was acquired before the domain duplication event(s) that led to four-domain channels. The concentration range over which TPCs were blocked by Na V antagonists is similar to that for blockade of Na V (49) . This raises the possibility that the off-target effects of Na V antagonists on TPCs may contribute to their efficacy. We propose that this pharmacological site underwent diversification, accounting for the relatively selective actions of Ca V and Na V modifiers in the four-domain lineage. The evolution of this site is unlikely to be driven directly by selection pressure at the pharmacological level, although the existence of endogenous modifiers that manipulate ion channel activity cannot be ruled out. Perhaps more likely is that the emergence and subsequent divergence of the site is a secondary consequence of the selection pressures associated with an evolving pore-a key functional domain.
Our analyses also identified a novel clade of TPCs that show similarities to Ca V with respect to both putative pharmacology and ion selection. These data suggested that acidification of selectivity filters, likely reflecting acquisition of ion selectivity, again may have occurred before the putative domain duplication event(s) that led to four-domain channels. Molecular cloning and functional characterization of these TPCs is urgently required. Together, our analyses predict a potential trajectory for the evolution of voltage-gated ion channels and provide a framework for probing evolutionary relevant structural attributes of these ancient ion channels.
MATERIALS AND METHODS
Sequence and phylogenetic analyses
Multiple sequence alignment and phylogenetic reconstruction were performed essentially as described (28, 29) . Briefly, nonredundant protein sequences were aligned using either MAFFT or T-Coffee and columns containing more than 50% gaps were subsequently removed from the sequence alignment using GapStreeze (Gap Strip/Squeeze v 2.1.0). Unambiguous sequence alignments were then converted to PHYLIP or NEXUS format. Identifiers for metazoan and unicellular TPCs are listed in tables S1 and S2, respectively. ProtTest (50) was used to select the best-fit evolution model and parameter estimates for the phylogenetic analyses. Maximum likelihood phylogeny was performed using the GARLI web service (51) with the LG amino acid substitution model, empirical frequency estimation, and the four-category discrete g model (LG + G + F) selected by ProtTest and 100 bootstrap replicates. Consensus trees were obtained using the CONSENSE program from the PHYLIP package (version 3.69).
Homology modeling
Homology models for the pore regions (S5 and S6) of Strongylocentrotus purpuratus TPC1 (accession no. D1J6X7) (44), S. rosetta TPC1a (accession no. EGD80440) and TPCRb (accession no. EGD78654), and human Ca V 1.2 (accession no. Q13936) and Na V 1.2 (accession no. Q99250) were generated in Modeller 9.11 (http://salilab.org/modeller/) using the 2.7-Å crystal structure of voltage-gated Na + channel from A. butzleri (Na V Ab, PDB ID: 3RVY) as a template (6) . Sequences of the pore regions from each of the domains were aligned against the cognate template region, using ClustalW2 (http://www.ebi.ac.uk/Tools/msa/ clustalw2/). The alignments used for TPCs are shown in Fig. 2A and  fig. S2 . Alignments for Ca V and Na V corresponded to those reported in (40) . We used the "straightforward" alignment for Ca V and the adjusted alignment (around PH2) for Na V (40) . The large loops between S5 and PH1 and between PH2 and S6 in Ca V and Na V were excluded. For each domain, 100 models were initially generated, and the best model was chosen on the basis of the discrete optimized protein energy (DOPE) score implemented within Modeller (52) . Loops in TPCs were modeled using Robetta (http://robetta.bakerlab.org/) (53) . Domains were assembled as tetramers, using the Na V Ab structure as template. A head-to-tail (trans) arrangement for TPCs was assumed (13) . Pores were further refined with KoBaMIN (http://csb.stanford. edu/kobamin) (54) . The overall threedimensional quality of the individual domains was assessed using MolProbity (http:// molprobity.biochem.duke.edu/). Boundaries and the proportion of Ramachandranfavored residues for each domain are listed in table S3.
Docking
Docking of ligands was carried out as described previously (55) . Briefly, Ca V and Na V antagonists (obtained from the ZINC database; http://zinc.docking.org) were docked using AutoDock 4.2 (http:// autodock.scripps.edu/). We adopted a blind docking approach using a Grid map of 80 × 66 × 84 points in 0.375-Å spacings that encompassed the entire pore cavity. Polar hydrogens and the Gasteiger partial atomic charges were added to the protein and ligands, using AutoDockTools (http:// autodock.scripps.edu/resources/adt). Only the top-ranked poses (those with the lowest free energy of interaction) of the drugs were considered. For detailed inspection and analyses of the docked poses, ligand interaction diagrams were derived using LigPlot + (http://www.ebi.ac.uk/thornton-srv/software/ LigPlus). All structural representations were prepared using the PyMOL Molecular Graphics System. PDB files for channel models and docked ligands are available in folders S1 to S5.
Ca 2+ measurements
Sea urchin egg homogenates were prepared and loaded with Ca as described previously (56) . Ca 2+ release was measured by cuvette-based fluorimetry with the Ca 2+ indicators Fluo-3 or Fluo-4 (3 mM, Invitrogen). SKBR3 cells were cultured as described previously (16) and transfected with TurboFectin 8 (Origene) using a 3:1 ratio of reagent/ plasmid. The C-terminally green fluorescent protein-tagged TPC1 construct from S. purpuratus was described in (44) . Ca 2+ imaging with Fura-2 and NAADP microinjection (pipette concentration 1 mM) were performed as described in (23) . Fluorescence intensity (Fluo dyes) and ratio (Fura-2) values were normalized to values before stimulation and presented as F/F 0 or R/R 0 , respectively. All agonists and drugs were from Sigma. 
